Yahoo Web Search

Search results

1. • 

     Adaptimmune Therapeutics PLC (ADAP) Loses -28.34% in 4 Weeks, Here's Why a Trend Reversal May be...

     Zacks via Yahoo Finance· 6 months ago

     Adaptimmune Therapeutics PLC (ADAP) is technically in oversold territory now, so the heavy selling...

2. • 

     Adaptimmune Therapeutics (NASDAQ:ADAP shareholders incur further losses as stock declines 22% this...

     Simply Wall St. via Yahoo Finance· 4 months ago

     This month, we saw the Adaptimmune Therapeutics plc (NASDAQ:ADAP) up an impressive 58%. But only the...

3. • 

     Adaptimmune Therapeutics PLC (ADAP) Stock Moves -1.24%: What You Should Know

     Zacks via Yahoo Finance· 3 months ago

     The most recent trading session ended with Adaptimmune Therapeutics PLC (ADAP) standing at $1.20,...

4. • 

     Even after rising 48% this past week, Adaptimmune Therapeutics (NASDAQ:ADAP) shareholders are still...

     Simply Wall St. via Yahoo Finance· 1 year ago

     Adaptimmune Therapeutics plc (NASDAQ:ADAP) shareholders will doubtless be very grateful to see the...

5. • 

     Adaptimmune (ADAP) Rises as GSK Transfers T-Cell Therapy IND

     Zacks via Yahoo Finance· 6 months ago

     Adaptimmune (ADAP) shares rise as GSK transfers IND for letetresgene autoluecel (lete-cel), which is...

6. • 

     Buy 5 Top-Ranked Stocks With Rising P/E in July

     Zacks via Yahoo Finance· 11 months ago

     Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include OpGen (OPGN), Adaptimmune Therapeutics (ADAP),...

7. • 

     Adaptimmune (ADAP) to Report Q2 Earnings: What's in the Cards?

     Zacks via Yahoo Finance· 10 months ago

     Adaptimmune (ADAP) is expected to provide regulatory and developmental updates on its pipeline...

8. • 

     Hedge funds investors may adopt severe steps after Adaptimmune Therapeutics plc's (NASDAQ:ADAP)...

     Simply Wall St. via Yahoo Finance· 1 year ago

     Every investor in Adaptimmune Therapeutics plc (NASDAQ:ADAP) should be aware of the most powerful...

9. • 

     Analysts Have Just Cut Their Adaptimmune Therapeutics plc (NASDAQ:ADAP) Revenue Estimates By 25%

     Simply Wall St. via Yahoo Finance· 2 years ago

     Today is shaping up negative for Adaptimmune Therapeutics plc (NASDAQ:ADAP) shareholders, with the...

10. • 

      New Forecasts: Here's What Analysts Think The Future Holds For Adaptimmune Therapeutics plc...

      Simply Wall St. via Yahoo Finance· 2 years ago

      Celebrations may be in order for Adaptimmune Therapeutics plc (NASDAQ:ADAP) shareholders, with the...